Summary Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis Essential resource for top-line data and analysis covering the Germany generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key Highlights - For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the ’generic-eligible’ market, are not included. - The German generics market had total revenues of $17.3bn in 2017, representing a compound annual growth rate (CAGR) of 1.7% between 2013 and 2017. - Market consumption volume increased with a CAGR of 0.3% between 2013 and 2017, to reach a total of 88.2% in 2017. - Germany has one of the highest generics market share globally so with the market close to saturation, growth in market consumption isn’t expected to grow drastically but there is still potential for slow growth.
Scope - Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Germany - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Germany - Leading company profiles reveal details of key generics market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Germany generics market with five year forecasts by both value and volume
Reasons to buy - What was the size of the Germany generics market by value in 2017? - What will be the size of the Germany generics market in 2022? - What factors are affecting the strength of competition in the Germany generics market? - How has the market performed over the last five years? - How large is Germany’s generics market in relation to its regional counterparts?
Our reports have been used by over 10K customers, including:
96 pages •
By Euromonitor International
• Feb 2019
Expats, who constitute one third of the total population, are declining in number within Saudi Arabia, resulting from the Saudisation programme and expat fees, which is adversely affecting consumer health sales. Many expat workers are being discharged by their employers or facing difficulties maintaining their current jobs and the burden of...
Nocturia - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H1 2019, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need...
Botulism - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Pipeline Review, H1 2019, provides an overview of the Botulism (Infectious Disease) pipeline landscape. Botulism is a rare but serious illness. The cause...
Image Guided Surgery Devices - Medical Devices Pipeline Assessment, 2019 Summary GlobalData’s Medical Devices sector report, “Image Guided Surgery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Image Guided Surgery Devices currently in pipeline stage. The report...
Biopsy Needles - Medical Devices Pipeline Assessment, 2019 Summary GlobalData’s Medical Devices sector report, “Biopsy Needles - Medical Devices Pipeline Assessment, 2019" provides an overview of Biopsy Needles currently in pipeline stage. The report provides comprehensive information on the...
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins,...
21 Companies Make Active Investments in Rett Syndrome Pipeline Drugs The global demand for Rett Syndrome treatment options is emerging rapidly driven by demand in major emerging and developed markets. An increasing number of companies are working on Rett Syndrome pipeline. Companies quickly adapting to the new technologies both independently...
16 Companies Make Active Investments in Nicotine Addiction Pipeline Drugs The global demand for Nicotine Addiction treatment options is emerging rapidly driven by demand in major emerging and developed markets. An increasing number of companies are working on Nicotine Addiction pipeline. Companies quickly adapting to the new technologies...
9 Companies Make Active Investments in Fatigue Pipeline Drugs The global demand for Fatigue treatment options is emerging rapidly driven by demand in major emerging and developed markets. An increasing number of companies are working on Fatigue pipeline. Companies quickly adapting to the new technologies both independently and through...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.